Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
in the face of mounting pressure, pharmaceutical manufacturers have abandoned their challenge against the South African Government over the pricing of aids medication. After more than 24 hours of final negotiations, the pharmaceutical companies and the South African Government reached agreement. The withdrawal paves the way to the production and …
the Union ministry of health and family welfare has banned the manufacture and sale of eight drug combinations, as they have no therapeutic value or contain ingredients for which there are no justifications. Manufacturers have to restrict production of these eight combinations so that no stocks are available after December …
Unlike sub-Saharan African countries, Brazil will not get discounts on two Acquired Immuno Deficiency Syndrome (aids) drugs that us-based Merck and Co Incorporation is planning to offer. "The discount on crixivan and stocrin is not applicable to Brazil,' said Marcos Levy, director of corporate affairs at Merck's Brazil unit. Responding …
cipla Limited of Mumbai has invited the wrath of multinationals companies (mncs) for offering to sell aids drugs at a cheap prices. The company proposes to sell the medicines to non-government organisations and doctors who would then distribute it in South Africa, where aids cases are high. The lowest price …
A nation like South Africa is the most dramatic example of a situation where drugs are available that would make a big difference to a sizeable part of its population that has been infected by the hiv virus but the people cannot afford to buy them. The country has more …
More than 40 pharmaceutical companies, including the world's largest and most powerful ones, will file a lawsuit against the South African government in a bid to stop it from passing a legislation aimed at reducing the price of medicines. The companies had tried to stop the South African parliament from …
the Washington Post has made damning discoveries on how foreign drugs firms, some of them based in the us , have been using African and Latin Americans as guinea pigs in testing risky drugs. The same paper had blown the lid on the administration of a drug, Trovan Floxacin, on …
the discount scheme recently introduced by five leading pharmaceutical companies for aids drugs in developing countries is just a charade, reports the International Herald Tribune . The companies had pledged to bring down the prices of patented aids drugs. But it seems this has not happened except for in some …
the past few years have seen an alarming increase in the number of malaria cases. The World Health Organisation ( who ) puts the annual number of cases between 300-500 million, and deaths between 1.5-2.7 million. Controlling the disease has become difficult due to insecticide resistance in the mosquito and …
across the world, silent and ceaseless crises regarding public health and environmental degradation urgently require the mobilisation of global science and technology. Gearing technological innovation towards solving the crises, by meeting the needs of the poor and the environment in which they live, is among the most critical challenges of …
South Africa and Namibia have rejected an offer of the us to provide financial assistance for purchasing anti- aids drugs. A total of us $1 billion was offered by the us Export-Import Bank to 24 sub-Saharan countries in annual loans. Bank officials said that till now none of the countries …
the high cost of drugs to fight hiv/aids in developing countries was a recurring theme at the 13th International aids conference held in Durban, South Africa, in the second week of July. The official opening ceremony was preceded by a protest march of several thousand people organised by the Treatment …
don corleone was probably the most popular citizen in the us when Hollywood made the film The Godfather . He used to make people offers they couldn't refuse. If they did they wound up dead. In the case of Africa, the local people and the government have been made an …
The South African government has severely criticised an offer of Pfizer Incorporation, a pharmaceutical company, to supply a powerful and expensive drug called Diflucan free of cost. Diflucan is used to treat a deadly AIDS-related infection. According to government officials, the offer is too restrictive to be of much benefit …
with the advent of a new technology to remove chloroform, it has now become possible to clean and reuse the wastewater from pharmaceutical plants. Called the Purolite adsorbant technology, it removes chlorinated solvents from wastewater streams. Not only does it prevent the release of possibly dangerous wastes but can also …
If malaria experts are to be believed, Kenyan health authorities could face serious embarrassment in the future for their reluctance to fully commit themselves to a programme designed to make an effective malaria drug. The project, known as Malarone Donation Programme, is supported by Glaxo Wellcome, a multinational pharmaceutical company. …
It is an issue that affects millions of consumers in the US . At stake are the interests of the pharmaceutical companies, insurance companies and the government. For years, the pharmaceutical industry was profiting from a friendly government and non-powerful consumer organisations. Not anymore. Now, protests are beginning to be …
- Lobbies for extension of patent rights, thus preventing the production of cheaper generics - Increases lobbying expenditures and contributes to parties' campaign funds, thereby warding off government interference - Introduces cheaper generics just when its patent is due to expire, thus making profits from both the original and the …
The Indian Drug Manufacturers' Association (idma) has moved the Bombay High Court challenging various issues laid down in the amendments to the 1972 Patent Rules. The government had, in early June, notified the amendments to the Patent Rules following the enactment of the Patents (Amendment) Act, 1999. The petition, it …
anti-hiv drug: Pharmaceutical company Glaxo has added yet another anti-HIV drug to its existing list. With the approval from 15 countries in Europe, the new drug Ziagen is a reverse transcriptase inhibitor, intended to be used as part of a cocktail of anti-retroviral drugs. Though Glaxo is the market leader …
